Philip Morris International (PM) Earnings Date & Reports
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US... Show more
PM is expected to report earnings to rise 4.08% to $2.04 per share on July 22
Philip Morris International (PM) Q1 2026 Earnings Recap: Smoke-Free Surge Powers EPS Beat
Key Takeaways
- Adjusted diluted EPS rose 16.0% to $1.96, surpassing consensus estimates of $1.83.
- Net revenues increased 9.1% to $10.1 billion, beating expectations around $9.9 billion.+Tops+Q1+EPS+by+13c,+Beats+on+Revenue;+Offers+Guidance/26346938.html)
- Smoke-free products hit 43% of total revenues, up 1.3 percentage points year-over-year, with international smoke-free revenues up 24.7%.
- IQOS heated tobacco units (HTUs) shipments grew 11.3%, making it the top nicotine brand in present markets.
- Full-year 2026 adjusted diluted EPS guidance updated to $8.36-$8.51, reflecting 10.9%-12.9% growth.
- Shares jumped about 6% following the release, signaling positive investor response.
Earnings Context and Why It Matters
Philip Morris International's Q1 2026 earnings highlight its ongoing pivot from traditional cigarettes to smoke-free products (SFPs), a critical shift amid declining combustible volumes and regulatory pressures on tobacco. With smoke-free now comprising 43% of revenues, these results underscore progress toward the company's ambition of 50% SFP revenue by 2030. Investors watch closely as this transition drives premium pricing and higher margins, while U.S. challenges like ZYN shipment declines test resilience. Strong international performance offsets domestic headwinds, making this report pivotal for assessing long-term growth in a maturing industry.
Philip Morris International reported net revenues of $10.1 billion for the first quarter ended March 31, 2026, up 9.1% on a reported basis and 2.7% organically from $9.25 billion in Q1 2025. This topped consensus expectations near $9.9 billion.+Tops+Q1+EPS+by+13c,+Beats+on+Revenue;+Offers+Guidance/26346938.html) International smoke-free revenues surged 24.7% (15.8% organically) to $3.8 billion, while combustibles rose 6.8% (1.0% organically) to $5.7 billion. U.S. revenues fell 30.8% to $0.6 billion amid ZYN (oral nicotine pouches) shipment declines.
Adjusted diluted earnings per share (EPS) climbed 16.0% to $1.96 from $1.69, exceeding analyst forecasts of $1.83; this reflects 5.3% growth excluding currency impacts. Reported diluted EPS dropped 9.3% to $1.56 due to a non-cash fair value adjustment on an India minority stake. Operating income grew 9.8% to $3.9 billion (0.9% organically). Key metrics included HTU shipments up 11.3% to 41.3 billion units and adjusted in-market sales (IMS) up 10.9%.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your investment strategy.
Market Reaction and Investor Sentiment
PM shares rose approximately 6% in the session following the April 22 earnings release, outperforming recent historical moves and reflecting optimism over the EPS beat and smoke-free momentum. Investors focused on IQOS strength and raised full-year guidance, though U.S. softness tempered some enthusiasm. Sentiment remains positive, buoyed by strategic progress in reduced-risk products amid a supportive regulatory environment in key markets.
Forward Outlook and Key Factors to Monitor
Philip Morris International reaffirmed robust 2026 guidance, projecting adjusted diluted EPS of $8.36 to $8.51, implying 10.9% to 12.9% growth versus 2025's $7.54. Excluding currency, the range is $8.11 to $8.26 (7.5% to 9.5% increase). Organic net revenue growth is expected at 5% to 7%, with operating income up 7% to 9%.
Shipment volumes should remain broadly stable, with high-single-digit smoke-free expansion offsetting a roughly 3% cigarette decline. Operating cash flow targets ~$13.5 billion, supporting $1.4 to $1.6 billion in capital expenditures for SFP capacity.
Investors should track international IQOS penetration, especially in Europe and emerging markets, where adjusted IMS grew robustly. U.S. ZYN recovery is crucial after shipment drops, despite offtake gains. Regulatory developments, pricing power in combustibles, and currency fluctuations will influence margin trends and guidance delivery.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Advertisement
General Information
a manufacturer of cigarettes and other tobacco products
Industry Tobacco